Wednesday, 3 September 2014


NYOH is the region's leading provider of community-based cancer care services.

The physicians and staff of New York Oncology Hematology (NYOH) are committed to reducing the incidence of cancer and blood diseases through earlier detection and intervention and offering their patients the most appropriate, evidence-based treatment options. With seven convenient locations, including five comprehensive cancer centers, the NYOH network provides world-class care to thousands of patients every year -- right here, close to home! Through our affiliation with US Oncology, one of the nation's largest cancer research networks, NYOH has played a pivotal role in the FDA approval process of 24 new anticancer drugs. Our special approach to cancer care allows us to have the best minds working together. To develop new treatments. To achieve more cures. To bring the breakthroughs home, as they happen!

New Patients






NYOH Hosts Congressman Tonko for Women’s Health Event


New York Oncology Hematology recently hosted a roundtable event with U.S. Representative Paul Tonko at our newly renovated Amsterdam Cancer Center.

Congressman Tonko invited local health care providers, patients and researchers to join NYOH for a discussion about the Affordable Care Act’s benefits for Capital Region women.

Arsyl De Jesus, MD, radiation oncologist at NYOH and Edwin Graham, Senior Vice President, US Oncology, were both featured speakers at the event.

Dr. De Jesus also demonstrated new radiation technology that is part of the $3 million investment in NYOH’s Amsterdam practice. The new technology allows doctors to more precisely define the size, shape and location of tumors, providing the most advanced cancer radiation therapy available in the Fulton Montgomery Counties region.

Read the Amsterdam Recorder story.